IBJNews

Pressure rises as Lilly tries squeeze play

Back to TopCommentsE-mailPrintBookmark and Share

Call it Lilly’s squeeze play.

Indianapolis-based Eli Lilly and Co. is now in the predicament of watching revenue fall as its patents on older products expire, even as the company needs to spend more money on marketing and research to boost sales of new drugs.

Lilly hopes it can score a run by launching new products before its high level of spending gets it thrown out at first base.

But its margin for error is even smaller than Wall Street analysts expected, which bumped Lilly’s stock price down a notch late last week. Lilly expects its 2012 profits to range between $3.10 and $3.20 per share, compared with analysts’ estimates of $3.61 per share.

Sales of Zyprexa, Lilly’s best-selling drug that lost patent protection in October, are falling faster than expected in international markets. Analysts thought the drug would bring in $2.1 billion this year, but Lilly now expects $500 million less than that.

Analysts also thought Lilly would reduce its spending this year compared with 2011—chopping $300 million—but now the firm says that’s not to be. It needs to boost sales efforts on its existing products. And it has to keep pouring money into its drug pipeline, which currently has an unprecedented 66 molecules in human trials. Twelve of those are in Phase 3, the final testing stage before regulatory approval.

“We’ve successfully rebuilt our mid- to late-stage pipelines to position Lilly for growth post-2014,” Derica Rice, Lilly’s chief financial officer, said during a Jan. 5 conference call with analysts and investors. But, he added, “the growth in our Phase 3 pipeline will ... create upward pressure on R&D spend.”

Lilly’s bet is that it can get enough of those molecules approved as new products to offset its loss of Zyprexa sales, as well as sales of four other blockbusters that are seeing patents expire by 2013.

But doing that requires money, something Lilly will have less of over the next three years. That’s not to say the company can’t afford that; it’s just a question of how much it has to chop its profits—or its work force—to get it done.

Lilly executives have been adamant that the company’s revenue won’t fall below $20 billion (from more than $24 billion last year) and its profits won’t dip below $3 billion (compared with nearly $5 billion last year).

To help in that process, Lilly over the past two years eliminated 5,500 jobs and cut its expenses $1 billion. But Citbank analyst John Boris doesn’t see how Lilly can stay above its minimum revenue and profit goals without more cuts—$900 million of them, he estimates.

“Therefore, we expect LLY to implement some level of cost cutting by [year’s end],” wrote Boris, referring to Lilly by its ticker symbol, in a Jan. 6 note to investors. And because he doesn’t expect Lilly’s pipeline to produce enough new sales to replace expiring blockbusters, Boris said Lilly will have to acquire more companies to get its sales and profits growing after 2014.

But not every analyst agrees entirely. Barclays Capital analyst Tony Butler expects Lilly’s pipeline to produce annual sales ranging between $2.5 billion and $4.5 billion by as early as 2015. And by 2020, he said, Lilly’s new products could be racking up $14 billion each year.

“However,” Butler noted, “these pipeline assets [which include the heart drug evacetrapib and the rheumatoid arthritis drug LY3009104], would require a significant amount of continued R&D investment.”

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. I keep wondering why I keep hearing about this problem of corporations leaving America, and I never hear a reasonable proposal to lower corporate tax rates and raise personal rates on income from capital gains and dividends, especially for high earners. It is just too simple of a solution for Congress to embrace?

  2. Are you financially down and you need money to settle your dept,or you need money to start up a business or to invest on a huge business,we also offer Loans to individuals, Firms and cooperate bodies at low interest rate , loan terms determinant,Loan amount between the sum of $5,000.00 to $100,000,000.00. US Dollars And Euro. Loan for developing businesses a competitive edge/ business expansion. We Offer The Following Kinds Of Loans. Personal Loans (Secure and Unsecured) Business Loans (Secure and Unsecured) Consolidation Loan FIRST INFORMATIONS NEEDED ARE: BORROWER’S DATA’S INFORMATION,FILL AND RETURN FOR QUICK START UP PROCESS. Name:_________ Last Name:_________ Age:_________ Contact Address:_________ Country:_________ Amount Needed as Loan:_________ Loan Duration:_________ Phone Number__________ Monthly Income/Yearly Income:_________ Purpose for Loan:_________ Occupation:_________ How Soon is Loan Needed__________ Email via: albertbrownfirm@outlook.com

  3. is a disaster. SR37 already needs to be built to interstate standards between 465 and SR144. Southport Road is a mess each morning and evening.

  4. Bass Pro Shops would be good for the mall as well as a Giant Eagle Market District or a Jungle Jim's International Market Place grocery store like the one near Cincinnati Ohio.A Disney quest indoor theme park would be good.An Academy outdoor store would be good too.Indoor Circus shows and magic shows would be good as well. A casino with sports bar would be good.A Disney theater inside that shows movies and Broadway shows would work.Nashville Tennessee concert shops with indoor neon lights would be good.How about a theater that shows travel shows and theme parks. A train store would be good.How about a giant toy store with high tech video games.

  5. This development is in addition to Allpoints Midwest 5, Aitrtek, a recent FedEx and more in Plainfield. Greenwood and Brownsburg also have similar projects.

ADVERTISEMENT